Prelude Therapeutics (PRLD) Other Accumulated Expenses (2019 - 2026)
Prelude Therapeutics' Other Accumulated Expenses was $630,000 in Q2 2026, down 26.8% from $861,000 a year earlier and down 30.8% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Other Accumulated Expenses at Prelude Therapeutics came in at $965,000, up 25.2% from FY2024.
- Other Accumulated Expenses shows a five-year compound annual growth rate of 18.1% (FY2020 to FY2025).
- In earlier years, Other Accumulated Expenses was $771,000 in FY2024 (-18.4%), $945,000 in FY2023 (+80.3%), $524,000 in FY2022 (+502.3%) and $87,000 in FY2021 (-79.3%).
- The Q2 2026 figure marks the lowest quarterly Other Accumulated Expenses since Q2 2024.
- Compared with a year earlier, Other Accumulated Expenses was higher in four of the last eight quarters, with growth averaging 13.1%.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q2 2022 (growth of 896.6%); the worst was Q4 2021 (a decline of 79.3%).
- Per Business Quant data, PRLD's Other Accumulated Expenses in the three quarters before Q2 2026 was $911,000 (Q1 2026), $965,000 (Q4 2025) and $963,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Prelude Therapeutics | 292.88 Mn | -304.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 630,000.00 |
| Mar 31, 2026 | 911,000.00 |
| Dec 31, 2025 | 965,000.00 |
| Sep 30, 2025 | 963,000.00 |
| Jun 30, 2025 | 861,000.00 |
| Mar 31, 2025 | 696,000.00 |
| Dec 31, 2024 | 771,000.00 |
| Sep 30, 2024 | 801,000.00 |
| Jun 30, 2024 | 455,000.00 |
| Mar 31, 2024 | 800,000.00 |
| Dec 31, 2023 | 945,000.00 |
| Sep 30, 2023 | 819,000.00 |
| Jun 30, 2023 | 809,000.00 |
| Mar 31, 2023 | 888,000.00 |
| Dec 31, 2022 | 524,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 289,000.00 |
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 87,000.00 |
| Sep 30, 2021 | 570,000.00 |
API Access
Prelude Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();